The SLC16 monocaboxylate transporter family

Xenobiotica

Volumn 38, Issue 7-8, 2008, Pages 1072-1106

  Meredith, D ^a   Christian, H C ^b  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aromatic amino acids; Drug delivery; Lactate; Monocarboxylate transporters; SLC16 family; Thyroid hormones

Indexed keywords

4 HYDROXYBUTYRIC ACID; LONIDAMINE; MERCAPTOPURINE; MEVALONIC ACID; MEVINOLIN; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 11; MONOCARBOXYLATE TRANSPORTER 12; MONOCARBOXYLATE TRANSPORTER 13; MONOCARBOXYLATE TRANSPORTER 14; MONOCARBOXYLATE TRANSPORTER 2; MONOCARBOXYLATE TRANSPORTER 3; MONOCARBOXYLATE TRANSPORTER 4; MONOCARBOXYLATE TRANSPORTER 5; MONOCARBOXYLATE TRANSPORTER 6; MONOCARBOXYLATE TRANSPORTER 7; MONOCARBOXYLATE TRANSPORTER 8; MONOCARBOXYLATE TRANSPORTER 9; NICOTINIC ACID; PRAVASTATIN; PROBENECID; ROSUVASTATIN; T TYPE AMINO ACID TRANSPORTER 1; VALPROIC ACID;

DATA BASE; DRUG TRANSPORT; MALARIA; MEMBRANE TRANSPORT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENOMICS; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; MONOCARBOXYLIC ACID TRANSPORTERS; MULTIGENE FAMILY; ORGAN SPECIFICITY; PHARMACOGENETICS; PROTEIN STRUCTURE, TERTIARY;

EID: 48749086146     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250802010868     Document Type: Review

References (161)

1. Alkemade A, Friesema EC, Kuiper GG, Wiersinga WM, Swaab DF, Visser TJ, Fliers E. 2006. Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary. European Journal of Endocrinology/European Federation of Endocrine Societies 154(3):491-500.
2. Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL, Wiersinga WM, Swaab DF, Visser TJ, Fliers E. 2005. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 90(7):4322-4334.
3. Aubert A, Costalat R, Magistretti PJ, Pellerin L. 2005. Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation. Proceedings of the National Academy of Sciences, USA 102(45):16448-16453.
4. Baker SK, McCullagh KJ, Bonen A. 1998. Training intensity-dependent and tissue-specific increases in lactate uptake and MCT-1 in heart and muscle. Journal of Applied Physiology 84(3):987-994.
5. Barth JD, Kruisbrink OA, Van Dijk AL. 1990. Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia. British Medical Journal (Clinical Research) 301(6753):669.
6. Ben-Horin H, Tassini M, Vivi A, Navon G, Kaplan O. 1995. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies. Cancer Research 55(13):2814-2821.
7. Bergersen L, Waerhaug O, Helm J, Thomas M, Laake P, Davies AJ, Wilson MC, Halestrap AP, Ottersen OP. 2001. A novel postsynaptic density protein: The monocarboxylate transporter MCT2 is co-localized with deltaglutamate receptors in postsynaptic densities of parallel fiber-Purkinje cell synapses. Experimental Brain Research. Experimentelle Hirnforschung 136(4):523-534.
8. Bergersen LH. 2007. Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle. Neuroscience 145(1):11-19.
9. Bhattacharya I, Boje KM. 2004. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier. Journal of Pharmacology and Experimental Therapeutics 311(1):92-98.
10. Bishop D, Edge J, Thomas C, Mercier J. 2007. High-intensity exercise acutely decreases the membrane content of MCT1 and MCT4 and buffer capacity in human skeletal muscle. Journal of Applied Physiology 102(2):616-621.
11. Blaheta RA, Michaelis M, Driever PH, Cinatl Jr J. 2005. Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies. Medicinal Research Reviews 25(4):383-397.
12. Bonen A. 2001. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle. European Journal of Applied Physiology 86(1):6-11.
13. Bonen A, Heynen M, Hatta H. 2006. Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle. Applied Physiology, Nutrition, and Metabolism [Physiologie Appliquee, Nutrition et Metabolisme] 31(1):31-39.
14. Boyd LM, Richardson WJ, Chen J, Kraus VB, Tewari A, Setton LA. 2005. Osmolarity regulates gene expression in intervertebral disc cells determined by gene array and real-time quantitative RT-PCR. Annals of Biomedical Engineering 33(8):1071-1077.
15. Brawer MK. 2005. Lonidamine: Basic science and rationale for treatment of prostatic proliferative disorders. Reviews in Urology 7(Suppl. 7):S21-S26.
16. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W. 2001. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 51(2):349-353.
17. Broer S. 2008. Amino acid transport across mammalian intestinal and renal epithelia. Physiological Reviews 88(1):249-286.
18. Broer S, Broer A, Schneider HP, Stegen C, Halestrap AP, Deitmer JW. 1999. Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochemical Journal 341(Pt 3):529-535.
19. Broer S, Rahman B, Pellegri G, Pellerin L, Martin JL, Verleysdonk S, Hamprecht B, Magistretti PJ. 1997. Comparison of lactate transport in astroglial cells and monocarboxylate transporter 1 (MCT 1) expressing Xenopus laevis oocytes. Expression of two different monocarboxylate transporters in astroglial cells and neurons. Journal of Biological Chemistry 272(48):30096-30102.
20. Broer S, Schneider HP, Broer A, Rahman B, Hamprecht B, Deitmer JW. 1998. Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH. Biochemical Journal 333(Pt 1):167-174.
21. Brooks GA. 1991. Current concepts in lactate exchange. Medicine and Science in Sports and Exercise 23(8):895-906.
22. Burgomaster KA, Cermak NM, Phillips SM, Benton CR, Bonen A, Gibala MJ. 2007. Divergent response of metabolite transport proteins in human skeletal muscle after sprint interval training and detraining. American Journal of Physiology Regul Integr Comp Physiology 292(5):R1970-R1976.
23. Buyse M, Sitaraman SV, Liu X, Bado A, Merlin D. 2002. Luminal leptin enhances CD147/MCT-1-mediated uptake of butyrate in the human intestinal cell line Caco2-BBE. Journal of Biological Chemistry 277(31):28182-28190.
24. Coles L, Litt J, Hatta H, Bonen A. 2004. Exercise rapidly increases expression of the monocarboxylate transporters MCT1 and MCT4 in rat muscle. Journal of Physiology 561(Pt 1):253-261.
25. Cranmer SL, Conant AR, Gutteridge WE, Halestrap AP. 1995. Characterization of the enhanced transport of L- and D-lactate into human red blood cells infected with Plasmodium falciparum suggests the presence of a novel saturable lactate proton cotransporter. Journal of Biological Chemistry 270(25):15045-15052.
26. Cuff MA, Shirazi-Beechey SP. 2004. The importance of butyrate transport to the regulation of gene expression in the colonic epithelium. Biochemical Society Transactions 32(Pt 6):1100-1102.
27. Dalsgaard MK, Ogoh S, Dawson EA, Yoshiga CC, Quistorff B, Secher NH. 2004. Cerebral carbohydrate cost of physical exertion in humans. American Journal of Physiology 287(3):R534-R540.
28. Deguchi Y, Nozawa K, Yamada S, Yokoyama Y, Kimura R. 1997. Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: Possible involvement of the monocarboxylic acid transport system. Journal of Pharmacology and Experimental Therapeutics 280(2):551-560.
29. Deguchi Y, Yokoyama Y, Sakamoto T, Hayashi H, Naito T, Yamada S, Kimura R. 2000. Brain distribution of 6-mercaptopurine is regulated by the efflux transport system in the blood-brain barrier. Life Sciences 66(7):649-662.
30. Deuticke B. 1982. Monocarboxylate transport in erythrocytes. Journal of Membrane Biology 70(2):89-103.
31. Deuticke B, Rickert I, Beyer E. 1978. Stereoselective, SH-dependent transfer of lactate in mammalian erythrocytes. Biochimica et Biophysica Acta 507(1):137-155.
32. Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F. 2003. Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today (Barcelona) 39(3):157-174.
33. Dimmer KS, Friedrich B, Lang F, Deitmer JW, Broer S. 2000. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochemical Journal 350(Pt 1):219-227.
34. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto Jr AM, et al. 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. pp 1615-1622.
35. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S. 2006. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 147(9):4036-4043.
36. Elliott JL, Saliba KJ, Kirk K. 2001. Transport of lactate and pyruvate in the intraerythrocytic malaria parasite, Plasmodium falciparum. Biochemical Journal 355(Pt 3):733-739.
37. Enoki T, Yoshida Y, Lally J, Hatta H, Bonen A. 2006. Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle. Journal of Physiology 577(Pt 1):433-443.
38. Evans M, Rees A. 2002. Effects of HMG-CoA reductase inhibitors on skeletal muscle: Are all statins the same? Drug Safety 25(9):649-663.
39. +-linked monocarboxylate transporter (MCT1/SLC16A1): A potential therapeutic target for high-risk neuroblastoma. Molecular Pharmacology 70(6):2108-2115.
40. Fliers E, Alkemade A, Wiersinga WM, Swaab DF. 2006a. Hypothalamic thyroid hormone feedback in health and disease. Progress in Brain Research 153:189-207.
41. Fliers E, Unmehopa UA, Alkemade A. 2006b. Functional neuroanatomy of thyroid hormone feedback in the human hypothalamus and pituitary gland. Molecular and Cellular Endocrinology 251(1-2):1-8.
42. Floridi A, Paggi MG, Marcante ML, Silvestrini B, Caputo A, De Martino C. 1981. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. Journal of the National Cancer Institute 66(3):497-499.
43. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ. 2003. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. Journal of Biological Chemistry 278(41):40128-40135.
44. Friesema EC, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ. 2006a. Mechanisms of disease: Psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. Nature Clinical Practice 2(9):512-523.
45. Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH. 2006b. Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Molecular Endocrinology (Baltimore) 20(11):2761-2772.
46. Galic S, Schneider HP, Broer A, Deitmer JW, Broer S. 2003. The loop between helix 4 and helix 5 in the monocarboxylate transporter MCT1 is important for substrate selection and protein stability. Biochemical Journal 376(Pt 2):413-422.
47. Garcia CK, Brown MS, Pathak RK, Goldstein JL. 1995. cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1. Journal of Biological Chemistry 270(4):1843-1849.
48. Garcia CK, Goldstein JL, Pathak RK, Anderson RG, Brown MS. 1994a. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: Implications for the Cori cycle. Cell 76(5):865-873.
49. Garcia CK, Li X, Luna J, Francke U. 1994b. cDNA cloning of the human monocarboxylate transporter 1 and chromosomal localization of the SLC16A1 locus to 1p13.2-p12. Genomics 23(2):500-503.
50. Gill RK, Saksena S, Alrefai WA, Sarwar Z, Goldstein JL, Carroll RE, Ramaswamy K, Dudeja PK. 2005. Expression and membrane localization of MCT isoforms along the length of the human intestine. American Journal of Physiology 289(4):C846-C852.
51. Gjedde A, Crone C. 1975. Induction processes in blood-brain transfer of ketone bodies during starvation. American Journal of Physiology 229(5):1165-1169.
52. Gladden LB. 2004. Lactate metabolism: A new paradigm for the third millennium. Journal of Physiology 558(Pt 1):5-30.
53. Green HJ, Duhamel TA, Holloway GP, Moule JW, Ranney DW, Tupling AR, Ouyang J. 2007. Rapid upregulation of GLUT4 and MCT4 expression during sixteen hours of heavy intermittent cycle exercise. American Journal of Physiology doi:10.1152/ajpregu.00699.2007.
54. Grollman EF, Philp NJ, McPhie P, Ward RD, Sauer B. 2000. Determination of transport kinetics of chick MCT3 monocarboxylate transporter from retinal pigment epithelium by expression in genetically modified yeast. Biochemistry 39(31):9351-9357.
55. Gruters A. 2007. Thyroid hormone transporter defects. Endocrine Development 10:118-a26.
56. Gupta N, Martin PM, Prasad PD, Ganapathy V. 2006. SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sciences 78(21):2419-2425.
57. Halestrap AP. 1976. Transport of pyruvate and lactate into human erythrocytes. Evidence for the involvement of the chloride carrier and a chloride-independent carrier. Biochemical Journal 156(2):193-207.
58. Halestrap AP, Denton RM. 1974. Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by alpha-cyano-4- hydroxycinnamate. Biochemical Journal 138(2):313-316.
59. Halestrap AP, Meredith D. 2004. The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Archives 447(5):619-628.
60. Halestrap AP, Price NT. 1999. The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochemical Journal 343(Pt 2):281-299.
61. Halestrap AP, Wang X, Poole RC, Jackson VN, Price NT. 1997. Lactate transport in heart in relation to myocardial ischemia. American Journal of Cardiology 80(3A):17A-25A.
62. Havel RJ, Rapaport E. 1995. Management of primary hyperlipidemia. New England Journal of Medicine 332(22):1491-1498.
63. 2+ signaling in astrocytes in situ. Journal of Biological Chemistry 280(42):35630-35640.
64. Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, Bauer K. 2005. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146(4):1701-1706.
65. Hirai T, Fukui Y, Motojima K. 2007. PPARalpha agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine. Biological and Pharmaceutical Bulletin 30(11):2185-2190.
66. Hu Y, Wilson GS. 1997. A temporary local energy pool coupled to neuronal activity: Fluctuations of extracellular lactate levels in rat brain monitored with rapid-response enzyme-based sensor. Journal of Neurochemistry 69(4):1484-1490.
67. Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C. 2000. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 118(4):724-734.
68. Iwanaga T, Takebe K, Kato I, Karaki S, Kuwahara A. 2006. Cellular expression of monocarboxylate transporters (MCT) in the digestive tract of the mouse, rat, and humans, with special reference to slc5a8. Biomedical Research (Tokyo) 27(5):243-254.
69. Jackson VN, Price NT, Carpenter L, Halestrap AP. 1997. Cloning of the monocarboxylate transporter isoform MCT2 from rat testis provides evidence that expression in tissues is species-specific and may involve post-transcriptional regulation. Biochemical Journal 324(Pt 2):447-453.
70. Jansen J, Friesema EC, Milici C, Visser TJ. 2005. Thyroid hormone transporters in health and disease. Thyroid 15(8):757-768.
71. Jones DT. 2007. Improving the accuracy of transmembrane protein topology prediction using evolutionary information. Bioinformatics (Oxford) 23(5):538-544.
72. Jones DT, Taylor WR, Thornton JM. 1994. A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 33(10):3038-3049.
73. Jukema JW, Bruschke AV, Van Boven AJ, Reiber JH, Bal ET, Zwinderman AH, Jansen H, Boerma GJ, Van Rappard FM, Lie KI et al. 1995. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91(10):2528-2540.
74. Kanaani J, Ginsburg H. 1991. Transport of lactate in Plasmodium falciparum-infected human erythrocytes. Journal of Cellular Physiology 149(3):469-476.
75. Kido Y, Tamai I, Okamoto M, Suzuki F, Tsuji A. 2000. Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharmaceutical Research 17(1):55-62.
76. Kim CM, Goldstein JL, Brown MS. 1992. cDNA cloning of MEV, a mutant protein that facilitates cellular uptake of mevalonate, and identification of the point mutation responsible for its gain of function. Journal of Biological Chemistry 267(32):23113-23121.
77. +/monocarboxylate transporters. Journal of Biological Chemistry 276(20):17221-17228.
78. Kim DK, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T, Endou H. 2002. The human T-type amino acid transporter-1: Characterization, gene organization, and chromosomal location. Genomics 79(1):95-103.
79. Kirat D, Inoue H, Iwano H, Hirayama K, Yokota H, Taniyama H, Kato S. 2005. Expression and distribution of monocarboxylate transporter 1 (MCT1) in the gastrointestinal tract of calves. Research in Veterinary Science 79(1):45-50.
80. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP. 2000. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO Journal 19(15):3896-3904.
81. Kobayashi M, Otsuka Y, Itagaki S, Hirano T, Iseki K. 2006. Inhibitory effects of statins on human monocarboxylate transporter 4. International Journal of Pharmaceutics 317(1):19-25.
82. Koehler-Stec EM, Simpson IA, Vannucci SJ, Landschulz KT, Landschulz WH. 1998. Monocarboxylate transporter expression in mouse brain. American Journal of Physiology 275(3 Pt 1):E516-E524.
83. Lafreniere RG, Carrel L, Willard HF. 1994. A novel transmembrane transporter encoded by the XPCT gene in Xq13.2. Human Molecular Genetics 3(7):1133-1139.
84. Leino RL, Gerhart DZ, Drewes LR. 1999. Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: A quantitative electron microscopic immunogold study. Brain Research Development Brain Research 113(1-2):47-54.
85. Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, Lutterbaugh J, Rerko RM, Casey G, Issa JP et al. 2003. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proceedings of the National Academy of Sciences, USA 100(14):8412-8417.
86. Liebowitz MR, Fyer AJ, Gorman JM, Dillon D, Appleby IL, Levy G, Anderson S, Levitt M, Palij M, Davies SO et al. 1984. Lactate provocation of panic attacks. I. Clinical and behavioral findings. Archives of General Psychiatry 41(8):764-770.
87. Lin RY, Vera JC, Chaganti RS, Golde DW. 1998. Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. Journal of Biological Chemistry 273(44):28959-28965.
88. Manning Fox JE, Meredith D, Halestrap AP. 2000. Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. Journal of Physiology 529(Pt 2):285-293.
89. Manoharan C, Wilson MC, Sessions RB, Halestrap AP. 2006. The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity. Molecular Membrane Biology 23(6):486-498.
90. McCullagh KJ, Poole RC, Halestrap AP, O'Brien M, Bonen A. 1996. Role of the lactate transporter (MCT1) in skeletal muscles. American Journal of Physiology 271(1 Pt 1):E143-E150.
91. Meredith D, Bell P, McClure B, Wilkins R. 2002. Functional and molecular characterisation of lactic acid transport in bovine articular chondrocytes. Cell Physiology and Biochemistry 12(4):227-234.
92. Meredith D, Price RA. 2006. Molecular modeling of PepT1 - towards a structure. Journal of Membrane Biology 213(2):79-88.
93. Meredith D, Roberts M, Halestrap AP. 1999. Both K290 and K413 are essential for DIDS covalent modification of the rat proton-linked monocarboxylate (lactate) transporter MCT1 expressed in Xenopus laevis oocytes. Journal of Physiology 517P:25P.
94. Merezhinskaya N, Fishbein WN, Davis JI, Foellmer JW. 2000. Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport. Muscle and Nerve 23(1):90-97.
95. Messonnier L, Denis C, Feasson L, Lacour JR. 2006. An elevated sarcolemmal lactate (and proton) transport capacity is an advantage during muscle activity in healthy humans. Journal of Applied Physiology doi:10.1152/japplphysiol.00807.2008.
96. + transport capacity for work production during supramaximal exercise in humans. Journal of Applied Physiology 102(5):1936-1944.
97. Mohr M, Krustrup P, Nielsen JJ, Nybo L, Rasmussen MK, Juel C, Bangsbo J. 2007. Effect of two different intense training regimens on skeletal muscle ion transport proteins and fatigue development. American Journal of Physiology 292(4):R1594-R1602.
98. Morgenstern B. 2004. DIALIGN: Multiple DNA and protein sequence alignment at BiBiServ. Nucleic Acids Research 32(Web Server issue):W33-W36.
99. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. 2000. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? Journal of Clinical Endocrinology and Metabolism 85(11):3975-3987.
100. Mortensen PB, Clausen MR. 1996. Short-chain fatty acids in the human colon: Relation to gastrointestinal health and disease. Scandinavian Journal of Gastroenterology 216:132-148.
101. Munro E, Patel M, Chan P, Betteridge L, Clunn G, Gallagher K, Hughes A, Schachter M, Wolfe J, Sever P. 1994. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: The role of isoprenoid intermediates of cholesterol synthesis. European Journal of Clinical Investigation 24(11):766-772.
102. Murakami Y, Kohyama N, Kobayashi Y, Ohbayashi M, Ohtani H, Sawada Y, Yamamoto T. 2005. Functional characterization of human monocarboxylate transporter 6 (SLC16A5). Drug Metabolism and Disposition: The Biological Fate of Chemicals 33(12):1845-1851.
103. Nagasawa K, Nagai K, Ishimoto A, Fujimoto S. 2003. Transport mechanism for lovastatin acid in bovine kidney NBL-1 cells: Kinetic evidences imply involvement of monocarboxylate transporter 4. International Journal of Pharmaceutics 262(1-2):63-73.
104. Nagasawa K, Nagai K, Sumitani Y, Moriya Y, Muraki Y, Takara K, Ohnishi N, Yokoyama T, Fujimoto S. 2002. Monocarboxylate transporter mediates uptake of lovastatin acid in rat cultured mesangial cells. Journal of Pharmaceutical Sciences 91(12):2605-2613.
105. Nehlig A, Boyet S, Pereira de Vasconcelos A. 1991. Autoradiographic measurement of local cerebral beta-hydroxybutyrate uptake in the rat during postnatal development. Neuroscience 40(3):871-878.
106. Ochrietor JD, Linser PJ. 2004. 5A11/Basigin gene products are necessary for proper maturation and function of the retina. Developmental Neuroscience 26(5-6):380-387.
107. Ord JJ, Streeter EH, Roberts IS, Cranston D, Harris AL. 2005. Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. British Journal of Cancer 93(3):346-354.
108. Peterson GM, Naunton M. 2005. Valproate: A simple chemical with so much to offer. Journal of Clinical Pharmacy and Therapeutics 30(5):417-421.
109. Philp NJ, Ochrietor JD, Rudoy C, Muramatsu T, Linser PJ. 2003a. Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Investigative Ophthalmology and Visual Science 44(3):1305-1311.
110. Philp NJ, Wang D, Yoon H, Hjelmeland LM. 2003b. Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells. Investigative Ophthalmology and Visual Science 44(4):1716-1721.
111. Philp NJ, Yoon H, Grollman EF. 1998. Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. American Journal of Physiology 274(6 Pt 2):R1824-R1828.
112. Philp NJ, Yoon H, Lombardi L. 2001. Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia. American Journal of Physiology 280(5):C1319-C1326.
113. Pierre K, Parent A, Jayet PY, Halestrap AP, Scherrer U, Pellerin L. 2007. Enhanced expression of three monocarboxylate transporter isoforms in the brain of obese mice. Journal of Physiology 583(Pt 2):469-486.
114. + transporter isoforms MCT1 and MCT4 in human skeletal muscle. American Journal of Physiology 276(5 Pt 1):E843-E848.
115. Pollay M, Stevens FA. 1980. Starvation-induced changes in transport of ketone bodies across the blood-brain barrier. Journal of Neuroscience Research 5(2):163-172.
116. Poole RC, Cranmer SL, Halestrap AP, Levi AJ. 1990. Substrate and inhibitor specificity of monocarboxylate transport into heart cells and erythrocytes. Further evidence for the existence of two distinct carriers. Biochemical Journal 269(3):827-829.
117. Poole RC, Halestrap AP. 1991. Reversible and irreversible inhibition, by stilbenedisulphonates, of lactate transport into rat erythrocytes. Identification of some new high-affinity inhibitors. Biochemical Journal 275(Pt 2):307-312.
118. Poole RC, Halestrap AP. 1992. Identification and partial purification of the erythrocyte L-lactate transporter. Biochemical Journal 283(Pt 3):855-862.
119. Poole RC, Halestrap AP. 1993. Transport of lactate and other monocarboxylates across mammalian plasma membranes. American Journal of Physiology 264(4 Pt 1):C761-C782.
120. +/lactate cotransporter (MCT1). Biochemical Journal 320(Pt 3):817-824.
121. Price NT, Jackson VN, Halestrap AP. 1998. Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochemical Journal 329(Pt 2):321-328.
122. Prummel MF, Brokken LJ, Wiersinga WM. 2004. Ultra short-loop feedback control of thyrotropin secretion. Thyroid 14(10):825-829.
123. Py G, Eydoux N, Lambert K, Chapot R, Koulmann N, Sanchez H, Bahi L, Peinnequin A, Mercier J, Bigard AX. 2005. Role of hypoxia-induced anorexia and right ventricular hypertrophy on lactate transport and MCT expression in rat muscle. Metabolism: Clinical and Experimental 54(5):634-644.
124. Rafiki A, Boulland JL, Halestrap AP, Ottersen OP, Bergersen L. 2003. Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain. Neuroscience 122(3):677-688.
125. Rahman B, Schneider HP, Broer A, Deitmer JW, Broer S. 1999. Helix 8 and helix 10 are involved in substrate recognition in the rat monocarboxylate transporter MCT1. Biochemistry 38(35):11577-11584.
126. Ramadan T, Camargo SM, Herzog B, Bordin M, Pos KM, Verrey F. 2007. Recycling of aromatic amino acids via TAT1 allows efflux of neutral amino acids via LAT2-4F2hc exchanger. Pflugers Archives 454(3):507-516.
127. Ramadan T, Camargo SM, Summa V, Hunziker P, Chesnov S, Pos KM, Verrey F. 2006. Basolateral aromatic amino acid transporter TAT1 (Slc16a10) functions as an efflux pathway. Journal of Cellular Physiology 206(3):771-779.
128. Rechsteiner M, Rogers SW. 1996. PEST sequences and regulation by proteolysis. Trends in Biochemical Sciences 21(7):267-271.
129. Roediger WE. 1982. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83(2):424-429.
130. Roehrborn CG. 2005. The development of lonidamine for benign prostatic hyperplasia and other indications. Reviews in Urology 7(Suppl. 7):S12-S20.
131. Rogers S, Wells R, Rechsteiner M. 1986. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis. Science (New York) 234(4774):364-368.
132. Russell JL, Kushner MG, Beitman BD, Bartels KM. 1991. Nonfearful panic disorder in neurology patients validated by lactate challenge. American Journal of Psychiatry 148(3):361-364.
133. Saheki A, Terasaki T, Tamai I, Tsuji A. 1994. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharmaceutical Research 11(2):305-311.
134. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S et al. 2004. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nature Medicine 10(6):638-642.
135. Schaefer EJ. 1988. HMG-CoA reductase inhibitors for hypercholesterolemia. New England Journal of Medicine 319:1222-1223.
136. Semenza GL. 2001. Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology. Trends in Molecular Medicine 7(8):345-350.
137. Settle P, Mynett K, Speake P, Champion E, Doughty IM, Sibley CP, D'Souza SW, Glazier J. 2004. Polarized lactate transporter activity and expression in the syncytiotrophoblast of the term human placenta. Placenta 25(6):496-504.
138. Sherman IW. 1998. Sherman IW, editor. Malaria: Parasite biology, pathogenesis, and protection. ASM Press, USA, pp 135-143.
139. +-dependent nicotinate transport in primary cultures of astrocytes from rat cerebral cortex. Neuroscience Letters 392(3):207-212.
140. Simanjuntak MT, Tamai I, Terasaki T, Tsuji A. 1990. Carrier-mediated uptake of nicotinic acid by rat intestinal brush-border membrane vesicles and relation to monocarboxylic acid transport. Journal of Pharmacobio-Dynamics 13(5):301-309.
141. Sirvent P, Bordenave S, Vermaelen M, Roels B, Vassort G, Mercier J, Raynaud E, Lacampagne A. 2005. Simvastatin induces impairment in skeletal muscle while heart is protected. Biochemical and Biophysical Research Communications 338(3):1426-1434.
142. Skoyum R, Eide K, Berg K, Rofstad EK. 1997. Energy metabolism in human melanoma cells under hypoxic and acidic conditions in vitro. British Journal of Cancer 76(4):421-428.
143. Takanaga H, Maeda H, Yabuuchi H, Tamai I, Higashida H, Tsuji A. 1996. Nicotinic acid transport mediated by pH-dependent anion antiporter and proton cotransporter in rabbit intestinal brush-border membrane. Journal of Pharmacy and Pharmacology 48(10):1073-1077.
144. Tamai I, Sai Y, Ono A, Kido Y, Yabuuchi H, Takanaga H, Satoh E, Ogihara T, Amano O, Izeki S et al. 1999. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. Journal of Pharmacy and Pharmacology 51(10):1113-1121.
145. Tan SW, Zoeller RT. 2007. Integrating basic research on thyroid hormone action into screening and testing programs for thyroid disruptors. Critical Reviews in Toxicology 37(1-2):5-10.
146. Thibault R, De Coppet P, Daly K, Bourreille A, Cuff M, Bonnet C, Mosnier JF, Galmiche JP, Shirazi-Beechey S, Segain JP. 2007. Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology 133(6):1916-1927.
147. Thomas C, Perrey S, Lambert K, Hugon G, Mornet D, Mercier J. 2005. Monocarboxylate transporters, blood lactate removal after supramaximal exercise, and fatigue indexes in humans. Journal of Applied Physiology 98(3):804-809.
148. Topping DL, Clifton PM. 2001. Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiological Reviews 81(3):1031-1064.
149. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K, Heuer H. 2007. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. Journal of Clinical Investigation 117(3):627-635.
150. Ullah MS, Davies AJ, Halestrap AP. 2006. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. Journal of Biological Chemistry 281(14):9030-9037.
151. Visser WE, Friesema EC, Jansen J, Visser TJ. 2007. Thyroid hormone transport by monocarboxylate transporters. Best Practice and Research 21(2):223-236.
152. Wahl ML, Owen JA, Burd R, Herlands RA, Nogami SS, Rodeck U, Berd D, Leeper DB, Owen CS. 2002. Regulation of intracellular pH in human melanoma: Potential therapeutic implications. Molecular Cancer Therapeutics 1(8):617-628.
153. Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, Rofstad EK, Mueller-Klieser W. 1997. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. American Journal of Pathology 150(2):409-415.
154. Wang Q, Darling IM, Morris ME. 2006. Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: Role of monocarboxylate transporters. Journal of Pharmacology and Experimental Therapeutics 318(2):751-761.
155. Wang Q, Morris ME. 2007. The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells. Drug Metabolism and Disposition: The Biological Fate of Chemicals 35(8):1393-1399.
156. Wang X, Poole RC, Halestrap AP, Levi AJ. 1993. Characterization of the inhibition by stilbene disulphonates and phloretin of lactate and pyruvate transport into rat and guinea-pig cardiac myocytes suggests the presence of two kinetically distinct carriers in heart cells. Biochemical Journal 290(Pt 1):249-258.
157. Wilson MC, Jackson VN, Heddle C, Price NT, Pilegaard H, Juel C, Bonen A, Montgomery I, Hutter OF, Halestrap AP. 1998. Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter isoform MCT3. Journal of Biological Chemistry 273(26):15920-15926.
158. Wilson MC, Meredith D, Fox JE, Manoharan C, Davies AJ, Halestrap AP. 2005. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: The ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). Journal of Biological Chemistry 280(29):27213-27221.
159. Wilson MC, Meredith D, Halestrap AP. 2002. Fluorescence resonance energy transfer studies on the interaction between the lactate transporter MCT1 and CD147 provide information on the topology and stoichiometry of the complex in situ. Journal of Biological Chemistry 277(5):3666-3672.
160. Yokel RA, Wilson M, Harris WR, Halestrap AP. 2002. Aluminum citrate uptake by immortalized brain endothelial cells: Implications for its blood-brain barrier transport. Brain Research 930(1-2):101-110.
161. Yoon H, Fanelli A, Grollman EF, Philp NJ. 1997. Identification of a unique monocarboxylate transporter (MCT3) in retinal pigment epithelium. Biochemical and Biophysical Research Communications 234(1):90-94.